Early Immune System Development and Ontogeny (R01 Clinical Trial Optional)
Key Information
Due Date: January 7, 2029
Agency: United States Department of Health and Human Services
Source: Federal
Funding Categories:
Funding Amount: Not Specified
Funding Type: Grant
Match Required: No
Status: Posted
Contact Info:
grantsinfo@nih.gov
NIH Grants Information grantsinfo@nih.gov
NIH Grants Information grantsinfo@nih.gov
Overview
The purpose of this Notice of Funding Opportunity (NOFO) is tofurther elucidate the mechanisms of early immune development in utero, during the early post-natal period and during early childhood in neonates, infants, and children and adolescents with or without in-utero exposure to HIV or Anti-Retroviral Therapeutics (ART).This initiative aims to understand intricate mechanisms of immune cells at the maternal-fetal interface, T and B cell development and maturation in offspring, and local immune responses and the role of systemic immunity.
Show More
Key Dates
Posted Date: December 30, 2024
Application Due Date: January 7, 2029
Estimated Award Date: Not Specified
Additional Details
Eligible Applicants
- Private institutions of higher education
- County governments
- Native American tribal governments (Federally recognized)
- Others
- State governments
- Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education
- Small businesses
- City or township governments
- Native American tribal organizations (other than Federally recognized tribal governments)
- Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education
- For profit organizations other than small businesses
- Special district governments
- Public and State controlled institutions of higher education
- Independent school districts
- Public housing authorities/Indian housing authorities